Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Oncology News

ESMO oncology news aims to keep you up to date with the developments that affect you and your daily practice. 

Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.

Filter by:

1356 results

Cancer in Special Situations/ Populations

EMA Recommends Extension of Indications for Plerixafor

New indication concern combination with G-CSF to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours

Cytotoxic Therapy;  Haematological Malignancies

EMA Recommends Extensions of Indication for Lenalidomide

Change in one of the existing indications concerns combination therapy in adult patients with previously untreated multiple myeloma who are not eligible for transplant 

Cytotoxic Therapy;  Haematological Malignancies

EMA Recommends Extension of Indications for Pomalidomide

New indication concerns treatment of adult patients with multiple myeloma in combination with bortezomib and dexamethasone after at least one prior regimen including lenalidomide

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.